ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.048,32
0,30%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07665
0,08%
Bitcoin
64.307,15
0,48%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. AVROBIO Inc (AVRO)

  7. AVROBIO Inc (AVRO) News

AVRO

AVROBIO (AVRO)

AVROBIO Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:AVRO
DatumZeitQuelleÜberschriftSymbolFirma
27/02/202416h50PR Newswire (US)Kuehn Law Encourages CHRD, AVRO, KAMN, and CTLT Investors to Contact Law FirmNASDAQ:AVROAVROBIO Inc
23/02/202422h00Edgar (US Regulatory)Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:AVROAVROBIO Inc
06/02/202402h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVROAVROBIO Inc
06/02/202401h59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVROAVROBIO Inc
06/02/202401h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVROAVROBIO Inc
06/02/202401h56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVROAVROBIO Inc
01/02/202420h25PR Newswire (US)Kuehn Law Encourages ICVX, CSTR, AVRO, and CALB Investors to Contact Law FirmNASDAQ:AVROAVROBIO Inc
30/01/202422h47Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:AVROAVROBIO Inc
30/01/202422h07Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:AVROAVROBIO Inc
30/01/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVROAVROBIO Inc
30/01/202415h05Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:AVROAVROBIO Inc
30/01/202414h39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVROAVROBIO Inc
30/01/202414h00Business WireAVROBIO and Tectonic Therapeutic Announce MergerNASDAQ:AVROAVROBIO Inc
09/11/202322h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVROAVROBIO Inc
03/11/202321h15Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:AVROAVROBIO Inc
10/08/202322h32Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVROAVROBIO Inc
12/07/202313h13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVROAVROBIO Inc
12/07/202313h00Business WireAVROBIO to Explore Strategic AlternativesNASDAQ:AVROAVROBIO Inc
03/07/202319h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVROAVROBIO Inc
14/06/202323h20Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:AVROAVROBIO Inc
12/06/202313h20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVROAVROBIO Inc
12/06/202313h00Business WireAVROBIO Completes Sale of Cystinosis Gene Therapy Program for $87.5 MillionNASDAQ:AVROAVROBIO Inc
09/06/202322h12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVROAVROBIO Inc
08/06/202322h32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVROAVROBIO Inc
08/06/202322h32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVROAVROBIO Inc
08/06/202322h29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVROAVROBIO Inc
08/06/202322h28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVROAVROBIO Inc
08/06/202322h27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVROAVROBIO Inc
07/06/202318h07Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:AVROAVROBIO Inc
05/06/202322h25Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:AVROAVROBIO Inc
 Showing the most relevant articles for your search:NASDAQ:AVRO

Kürzlich von Ihnen besucht

AMEX
XLV
Health Care Select Sector
NASDAQ
AAPL
Apple
NYSE
MCD
McDonalds
NYSE
XOM
Exxon Mobil
TG
RHM
Rheinmetall
FX
EURGBP
Euro vs Sterling
DBI
TDXP
Tec DAX
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
MSFT
Microsoft
TG
NOV
Novo Nordisk
NYSE
MRK
Merck
NASDAQ
NVDA
NVIDIA
TG
432
Arbor Metals
TG
BAYN
Bayer
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten